Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.

Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.

Item
http://www.wikidata.org/entity/Q30419381
Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantationEffect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study.Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients.Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake.A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.
P2860

Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.

Item
http://www.wikidata.org/entity/Q30419381
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical outcomes in kidney tr ...... mammalian target of rapamycin.
@ast
Clinical outcomes in kidney tr ...... mammalian target of rapamycin.
@en
type
label
Clinical outcomes in kidney tr ...... mammalian target of rapamycin.
@ast
Clinical outcomes in kidney tr ...... mammalian target of rapamycin.
@en
prefLabel
Clinical outcomes in kidney tr ...... mammalian target of rapamycin.
@ast
Clinical outcomes in kidney tr ...... mammalian target of rapamycin.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Clinical outcomes in kidney tr ...... mammalian target of rapamycin.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1600-6143.2011.03826.X
P407
P433
P478
P577
P5875
P698
P932